Modulation Of Pilr To Treat Immune Disorders

Abstract

The present invention provides methods of using PILRa agonists, or PILRß antagonists, to treat immune disorders, such as autoimmune and inflammatory disorders, including CNS, joint and gut inflammation.


Claims

Sign in to the Lens

Feedback